Investors pour $7.1B into digital health investments during Q1 2021
Digital health funding continued to explode in the first quarter of 2021. In Q1 MobiHealthNews reported on a whopping 99 digital health fundings equaling $7.1 billion in venture dollars. This number trumps the $2.9 billion reported in 2020's Q1. While the number of fundings is on the rise, so is the amount as later-stage companies complete Series D and E rounds. For example, direct-to-consumer virtual care company Ro scored $500 million in fundings. But while Ro was top of the chart, nine-figure fundings aren't uncommon – in fact, MobiHealthNews reported on 28 fundings that topped $100 million. Read on for a full list of the fundings.Company | Round/Series | Amount (M) | Investors | What it’s for | What it does |
Ro | Series D | $500 | General Catalyst, FirstMark Capital and TQ Ventures | The company said the money is to expand its pharmacy distribution network, boost its EHR system, introduce remote monitoring and add other capabilites. |
The company offers direct-to-consumer virtual care and mail-order prescriptions for various conditions.
|
DXY | Series E | $500 | Trustbridge Partners, Tencent Investment and GL Ventures | In addition to reinforcing the core DXY.cn platform for Chinese doctors, the company will be focused on fleshing out its partnerships with hospitals, life science clients and other enterprises so that it can offer more services and resources. |
The company offers an online platform for providers, healthcare organizations and health consumers.
|
insitro | Series C | $400 | Canadian Pension Plan Investment Board and other participants | The company plans on using the fund to expand its platform’s capabilities and pipeline. |
The company uses artificial intelligence for drug discovery.
|
Keep | Series F | $360 | SoftBank Vision Fund, Hillhouse Capital, Coatue Management, GGV Capital, Tencent, 5Y Capital, Jeneration Capital and Bertelsmann Asia Investments. | The company said that it will continue to improve and add new products and services to its customers. |
Keep is a Chinese fitness brand offering live, at-home workouts and Peloton-like connected exercise machines.
|
Hinge Health | Series D | $300 | Coatue Management, Tiger Global, Atomico, Insight Partners, Quadrille, 11.2 Capital, Lead Edge Capital, Bessemer Venture Partners and Heuristic Capital. | Hinge Health will be using the money to deepen its MSK clinical capabilities and to pursue new partnerships within the Medicare Advantage space. |
Hinge Health sells in-home MSK therapy programs designed for individual or enterprise purchase, the latter type comprising the majority of its business.
|
Valo Health | Series B | $300 | Koch Disruptive Technologies | Valo plans to use the infusion of cash to build out its platform for discovery and development. |
The company’s Opal Computational Platform uses machine learning and patient data to inform the development of new therapeutics.
|
Forward | Series D | $225 | Founders Fund, Khosla Ventures, SoftBank Vision Fund 2, Marc Benioff and The Weeknd | The company will go towards new physical locations. |
The company’s services are a blend of in-person primary care and data-driven health monitoring.
|
Strive | Series B | $223.50 | CapitalG, Redpoint, NEA, Town Hall Ventures, Ascension Ventures and Echo Ventures | The new money will be put towards growing the company and go-to-market efforts. |
The company’s platform is able to integrate chronic kidney disease patient data from across various systems into one platform.
|
Komodo | Series E | $220 | Tiger Global, Casdin Capital, ICONIQ Growth, Andreessen Horowitz and Silicon Valley Bank. | It will go toward further investment in its enterprise technology platform, application suite and other core data assets. |
Komodo is a healthcare data analysis startup.
|
Cedar | Series D | $200 | Tiger Global Management, Andreessen Horowitz (a16z), Thrive Capital and Concord Health Partners | The new money to push its product road map outside of its core financial engagement product and focus on patient-engagement offerings, such as pre-visit price transparency tools. |
Cedar makes an intelligent patient billing and engagement platform.
|
Dispatch Health | Series D | $200 | Tiger Global, Alta Partners, Echo Health Ventures, Humana, Oak HC/FT and Questa Capital | The company plans on putting the money towards expanding its in-home care platform to 100 markets. |
Patients are able to request an at-home urgent care medical visit through Dispatch.
|
Cityblock | Series C | $192 | Tiger Global, Kinnevik AB, Maverick Ventures, General Catalyst, Wellington Management, Thrive Capital, Redpoint Ventures, Echo Health Ventures, 8VC and AIMS Imprint of Goldman Sachs Asset Management. | The company said the new funds will be going toward speeding up the development of its care model on a nationwide scale. |
Cityblock is focused on addressing the social determinants of health (SDOH) by using technology to help create support teams.
|
Lyra Health | Series E | $187 | Addition, Durable Capital Partners LP, Fidelity Management & Research Company and Baillie Gifford | Lyra’s funding will be used to further support company growth as it seeks partnerships. |
Lyra Health offers a digital behavioral health and coaching platform for employees.
|
Crossover Health | Series D | $168 | Deerfield Management Company, Perceptive Advisors, OrbiMed Advisors, Foresite Capital, Avidity Partners, SharesPost100 Fund, Irving Investors and PFM Health Sciences. | Crossover said it will continue expanding its Connected System of Health platform across the U.S. |
Crossover offers primary care and other services such as mental healthcare and health coaching to health-plan and self-insured employer members.
|
Color | Series D | $167 | General Catalyst, T. Rowe Price Associates and Viking Global Investors | The company plans on adding new members to its leadership team and scaling its operation |
Color created a digital population health and genomics infrastructure for use by public health institutions and initiatives.
|
Evidation | Series E | $153 | OMERS Growth Equity, Kaiser Permanente Group Trust, McKesson Ventures and B Capital Group. | The company is planning to use the new funds to expand its virtual health capabilities. |
Evidation combines real-world patient data from multiple sources
|
UniteUs | Series C | $150 | Iconiq Growth, Emerson Collective, Optum Ventures, Transformation Capital, Define Ventures, Salesforce Ventures, Town Hall Ventures and other healthcare partners. | The company plans putting the new infusion of cash into growing its footprint across the country. |
The New York-based company is focused on the social determinants of health.
|
Zocdoc | N/A | $150 | Francisco Partners | The company plans to use the new funds to invest in its sales and marketing teams, and to grow its product line. |
Patients can use the platform to search for a provider that takes their insurance and is close to their location.
|
K Health | Series E | $132 | GGV Capital, Valor Equity Partners, Kaiser Permanente pension fund, GGV Managing Partners, LTS Ventures, Atreides Ventures, 14W, Max Ventures, Pico Partners, Marcy Venture Partners, Primary Ventures and Box Group | The company will be focusing its investment on the new K for Parents offering and on further building out the K Health app. |
New York-based K Health has built an artificial intelligence system that chats with users about their health concerns, and also links to paid text-based telehealth.
|
Sidecar Health | Series C | $125 | Drive Capital, BOND, Tiger Global, Menlo Ventures, Cathay Innovations and GreatPoint Ventures | The company said that it’s targeting new products while expanding its team and geographic footprint. |
Sidecar Health’s members use the startup’s app to customize the amount of annual healthcare coverage they would like, and whether they would like coverage for prescriptions.
|
Paige | Series C | $125 | KKR, Casdin Capital and Johnson & Johnson | It will use the funds to expand its geographic footprint. |
The company created an AI-enabled diagnostic platform for oncologists and pathologists.
|
BetterUp | Series D | $125 | ICONIQ Growth, Lightspeed Venture Partners, Threshold Ventures, Plus Capital, Salesforce Ventures, Sapphire Ventures and Mubadala Capital | The company plans to use the new money to continue the development of products. |
The company offers behavioral health coaching.
|
Clarify Health | Series C | $115 | Insight Partners Spark Capital, Concord Health Partners, HWVP, KKR, Rivas Capital and Sigmas Group | The money will go towards scaling its self-service analytics cloud platform and business application. |
The platform is able to unify and analyze health data.
|
Innovacer | Series D | $105 | Tiger Global Capital, B Capital Group and Steadview Capital | The company has put the funds towards launching a suite of services and hiring more team members. |
The company employs AI and data analytics to help unify healthcare data for easier healthcare management.
|
BrightInsight | Series C | $101 | General Catalyst, Insight Partners, New Leaf Venture Partners and Eclipse Ventures. | With the new money, the company aims to invest in additional software modules, grow its team across all departments, and expand its reach within the Americas and Asia. |
It is a medical Internet of things company looking to serve as the infrastructure backbone of digital health products.
|
Paige | Series C | $100 | Casdin Capital and Johnson & Johnson Innovation. The startup’s prior backers and other unnamed funds also took part in the raise. | The funds will be used to build additional AI-based products within and outside of oncology, deliver these products to laboratories and clinicians globally, and invest in its talent across engineering and commercial functions. |
Paige uses computational and digital pathology to help oncologists and pathologists make decisions faster, more accurately and at a lower cost.
|
Rightway | Series C | $100 | Khosla Ventures, Thrive Capital, Tiger Global Management and other prior backers. | Rightway said it’s now looking to further build RightwayRx, the pharmacy benefits platform it launched last year. |
The company makes a digital care navigation and pharmacy benefits platform.
|
Ginger | Series E | $100 | Blackstone Growth |
The company offers on-demand behavioral health coaching and video therapy.
|
|
RapidSOS | Series C | $85 | Insight Partners | The fund will help it continue linking with more connected devices, systems and software, and also support partnerships with worldwide first-responder organizations. |
RapidSOS aims to provide emergency responders with accurate, real-time health and location data before they arrive on the scene.
|
23andMe | equity funding | $83 | Sequoia Capital and NewView Capital | N/A |
23andMe is a direct-to-consumer service, which provides insights to users about their DNA.
|
Pear Therapeutics | Series D | $80 | The company didn’t dislose funders | The Series D funding will be focused on securing reimbursement for its products. |
Pear is a digital therapeutics company.
|
Modern Health | Series D | $74 | Founder Fund, Lachy Groom, Battery Ventures, Kleiner Perkins Felicis Ventures and 01-Advisors | The company will use the money towards growth. |
Modern Health has created a mental health-and-wellness platform.
|
Happify Health | Series D | $73 | Deerfield Management Company, Omega Capital Partners, ION Crossover Partners and other prior backers. | The funds will fuel product partnerships and product development. |
The company developed a platform for mental health and disease management programs,
|
TimelyMD | N/A | $60 | JMI Equity | TimelyMD will grow its team, enhance students’ user experiences and improve health literacy at its partner institutions. |
The company acts as an extension of a school’s existing student health facilities, offering round-the-clock medical, mental health, psychiatry and health-coaching virtual visits.
|
Eden Health | Series C | $60 | Insight Partners, Amigo Health, Aspect Ventures, Company Ventures, Flare Capital, Flexcap Ventures, Max Ventures and PJC | The money will help fuel expansion of brick-and-mortar offices. |
Eden is a direct-to-employer health provider that offers virtual primary care, insurance navigation and workplace pop-up clinics.
|
Circulo | N/A | $50 | Drive Capital, General Catalyst, Oack HC/FT and SVB Capital | The startup is looking to get off the ground by adding “dozens” of new hires to its team as soon as possible. |
Circulo is an insurtech startup targeting the Medicaid population.
|
Capital Rx | Series B | $50 | Transformation Capital and Edison Partners. | The company is planning on expanding the tool to include AI to inform clinical care. |
The company’s offerings include an enterprise pharmacy platform and integrated patient mobile app called JUDI.
|
Carrum Health | Series A | $40 | Tiger Global Management, GreatPoint Ventures, Cross Creek, Wildcat Venture Partners and SpringRock Ventures. | The startup said that it wants to push its offering out to more employers, add more healthcare services to its market and improve its technology. |
Carrum Health is a digital marketplace that allows employers to purchase bundled healthcare services
|
Ibex Medical | Series B | $38 | Octopus Ventures, 83North, aMoon, Planven Entrepreneur Ventures and Dell Technologies Capital | The new funds will help expand its clinical deployments across North America and Europe. |
Ibex’s Galen platform uses AI and machine learning to reduce the burden on pathologists as they review biopsies.
|
Koa Health | Series A | $36 | Wellington Partners Life Sciences, Ancora Finance Group, MTIP, Akilia Partners, Creas Impacto, Sabadell Asabys and Mundi Ventures | The company plans on using the new funds to fuel product development and build out more products in more languages |
Koa has a mental wellbeing app designed for the employee wellness space.
|
Manual | Series A | $30 | Sonoma Brands, Felix Capital, Cherry Ventures, Waldencast, Gisev and FJ Labs all participated in the funding round. | The U.K. -based company plans to use the money for product development, as well as expanding into the international market. |
Customers can tap into the platform to seek treatment for hair loss, erectile dysfunction, skincare and other daily health concerns.
|
Glooko | Series D | $30 | Health Catalyst Capital, Canaan Partners, Georgian, Novo Nordisk, Insulet and Mayo Clinic | The funds will boost its efforts to increase adoption of the remote monitoring platform and fuel commercialization. |
The platform acts as a central hub for connected monitoring devices and other disease-relevant data streams.
|
PocketPills | Series B | $30 | TELUS Ventures and WaterBridge Ventures | Its new money will go toward its technology and pharmacy automation, and will also help open new locations in Alberta and Quebec. |
The company is an online pharmacy.
|
Medisafe | Series C | $30 | Sanofi Ventures and ALIVE Israel HealthTech Fund | The company plans to use the fund to invest in expanding its platform and accelerating its revenue growth. |
The company is focused on medication management.
|
Blue Note Therapeutics | Series A | $26.25 | JAZZ Venture Partners and Summer VC | Blue Note said that it will also be looking to scale its organization and develop other assets in its pipeline. |
The company created prescription digital therapeutics for anxiety and depression related to cancer.
|
SWORD Health | Series B | $25 | Transformation Capital, Khosla Ventures, Founders Fund, Green Innovations, Vesalius Biocapital and Faber | The company plans to use the funds to further accelerate its substantial growth during the previous year. |
SWORD Health provides employer-based virtual physical therapy with a focus on musculoskeletal disorders.
|
Folx Health | N/A | $25 |
Bessemer Venture Partners, Define Ventures and Polaris
|
Folx provides virtual health and home testing services designed for LGBTQIA+ patients.
|
|
SteadyMD | Series B | $25 | Lux Capital, Sound Ventures, Acrew Capital and other digital health investors. | The company said the new funds will continue to fuel its expansion across the U.S. |
The company works with employer organizations and digital health companies in order to link up users with virtual care.
|
100Plus | seed funding | $25 | Angel investors Henry Kravis and George Roberts | The company plans to use the new cash to fund the development of its AI tool, aimed at driving patient engagement |
The company’s platform is dedicated to supporting clinicians in remotely monitoring patients.
|
Folx | Seed funding | $25 | Bessemer Venture Partners, Define Ventures and Polaris | Over the next year the company is looking to expand its footprint to a national level and expand its offerings. |
Folx is an LGBTQIA+ focused digital health provider.
|
Calibrate | Series A | $22.50 | Threshold Ventures, Forerunner Ventures and Redesign Health | The company is looking to expand its tech platform and data infrastructure. |
Calibrate is a digital weight-management platform incorporating an app, virtual visits, medication and connected scales.
|
NeuroFlow | Series B | $20 | Magellan Health and the startup’s prior backers. | Going forward, the company will be scaling its operations and growing its data analytics, AI and direct health record integrations. |
NeuroFlow offers a suite of digital tools that can be integrated into an organization’s EHR and systems to enable remote patient monitoring, population health management and other behavioral health capabilities.
|
CirrusMD | Series C | $20 | Blue Venture Fund, 7wireVentures, Drive Capital and the Colorado Impact Fund. | These funds will help the startup continue its growth momentum by supporting expanded capabilities, stronger user and provider experiences, greater scalability and other benefits for its customers. |
The company offers on-demand, text-first telehealth.
|
Carevive System | Series C | $18 | Philips Health Technology Ventures, Debiopharm Innovation Fund, OurCrowd’s digital health fund, Qure Ventures, HLM Venture Partners, LRVHealth and Cerner | Carevive plans on using the money to invest in tech, data analytics and infrastructure. |
The digital health company focuses on personalized care for oncology patients.
|
Theator | Series A | $15.50 | Insight Partners, Blumberg Capital, prior investors NFX, StageOne Ventures, KdT Ventures, iAngels and a slew of individual investors | With the new funds, the company said it will be scaling its commercial operations and provider partnerships while growing its R&D team. |
The company is building an AI and computer vision platform for surgeons.
|
Flywheel | Series B | $15 | Beringea, 8VC, Novartis dRx Capital, Hewlett Packard Enterprise, Great North Labs, iSelect and Argonautic Ventures | The company said the new funds will fuel its growth in the life science and AI research space. |
The company is focused on the research industry, including the life sciences space, clinical research and AI for developers.
|
Lumiata | Series B | $14 | Defy.vc, AllegisNL Capita, Khosla Ventures and Blue Venture Fund. | With the money, it plans to grow its platform, invest in new customer acquisition and open a new office in Guadalajara, Mexico. |
The machine learning and predictive analytics company says that its cloud-based product is scalable and can integrate with healthcare companies’ existing systems.
|
Sitka | Series A | $14 | Venrock, Optum Ventures, Homebrew, First Round Capital and Lifeforce Capital | The new capital will be put toward growing the product, expanding partnerships and recruiting new employees. |
Sitka makes a video software targeted toward specialty care.
|
Casana | Series A | $14 | General Catalyst and the Outsiders Fund | Casana said that its primary focus is seeing the Heart Seat through the process of FDA clearance and eventually bringing the device to market. |
Casana makes a cardiac health-monitoring smart toilet seat.
|
SocialClimb | N/A | $12 | Resolve Growth Partners | SocialClimb will be improving its tech and moving its services into new clinical specialties. |
The company’s offers automated messaging and tools focused on reputation management and targeted digital advertising for providers.
|
SpineZone | Series A | $12 | Polaris Partners, Providence Ventures and Martin Ventures. | The funds will go towards expanding its business via additional strategic partnerships and clinics in new markets |
The company is an online musculoskeletal (MSK) treatment provider.
|
actio | Seed funding | $12 | Heal Capital | The company did not outline specific plans for the new money. |
The company makes a health-and-wellness coaching app.
|
Insightin Health | Series A | $12 | Blue Venture Fund, Blue Heron Capital, Health Catalyst Capital, Revolution’s Rise of the Rest fund and SaaS Ventures | The company plans to use the new funds to scale its platform, onboard new clients and expand its services to meet client needs. |
The company is best known for its engagement platform targeted at insurance members.
|
Nayya | Series A | $11 | Felicis Ventures, Social Leverage, Guardian Life, Cameron Ventures, Unum Business Ventures. | The company said that the funds would help grow its New York and countrywide team. It would also support an expansion of its product portfolio, deepen the platform’s integrations and help secure new partnerships. |
Nayya is a maker of an insurance benefits platform.
|
Cohort | Series B | $11 | F-Prime Capital and Town Hall Ventures | The company plans to use the funds to grow its business across provider and payer systems, as well as expand the capabilities of its clinical AI/NLP platform and grow its team. |
Cohort is a care-management platform centered on at-risk populations.
|
ViBe Saúde | Series A | $10 | A group of Swedish investors | The company said that the money will help the company expand its “freemium” primary care business model. |
ViBe Saúde is a Brazilian digital health company that provides on-demand telehealth consultations to consumers, as well as other digital treatments for chronic care management
|
Lifelink Systems | Series A | $9.75 | DigiTX Partners, Primera Capital, Baleon Capital and other investors. | Lifelink plans to use the new funds to speed up the development of its conversational AI for healthcare companies. |
The chatbot company works with providers and life science companies to help with patient engagement.
|
January AI | N/A | $8.80 | Felis Ventures, AME Cloud Ventures, SignalFire and individual investors. | The new money will go towards new hires in product, engineering and operation teams. The new money will go towards new hires in product, engineering and operation teams. |
The company created an algorithm to help predict a users’ glycemic response to a large swath of foods.
|
Conversa | Series B add-on | $8 | Builders VC, Northwell Ventures, UH Ventures, P5 Health Ventures, Genesis Merchant Capital, J-Ventures, Epic Ventures, StartUp Health and Nassau Street Ventures | Conversa plans to continue to build out its platform. |
Conversa has an Automated Virtual Care and Triage platform that providers can use to remotely monitor, analyze and communicate with patients for a range of conditions.
|
Vessel | Seed funding | $8 | Monogram Capital Partners, Able, BFG, Cove, Sidekick and individual investors | The company did not outline how the new funds would be used. |
The in-home wellness testing startup allows users to quickly review results on an app.
|
PaceMate | Series A | $8 | Ballast Point Ventures | Per the announcement, the startup is aiming to expand the tech platform’s market reach. |
PaceMate offers an EHR-integrated software platform for monitoring data from implanted and wearable cardiac devices, as well as staffing support and remote monitoring services via live staff.
|
Vibrant | Series E | $7.50 | Unorthodox Ventures | The company plans to use the funds for go through its trials with the FDA. |
The Israeli company is behind an ingestible device that treats chronic constipation.
|
Dina | Series A | $7 | Osage Venture Partners and First Trust Capital Partners | The company will fuel the development of its care-coordination platform and expand its footprint to a national level. |
The platform uses artificial intelligence in order to enable care coordination for in-home care between different networks.
|
BurnAlong | N/A | $7 | Triventures | The company did not specify how the funds would be used. |
BurnAlong’s offering leans on video health and wellness content with social motivation and engagement features.
|
Bold | Seed funding | $7 | Andreessen Horowitz | The company did not specify how the funds would be used. |
The startup provides personalized virtual-exercise programs for aging populations.
|
Reperio Health | Seed funding | $6 | Caduceus Capital Partners, Rogue Venture Partners, Liquid 2 Ventures and G Ventures | Reperio said that the new funds would help accelerate its growth and support their initial employer market launch. Reperio said that the new funds would help accelerate its growth and support their initial employer market launch. |
The company makes of an app-connected home wellness-assessment kit marketed to employers.
|
OnlineDoctor | Series A | $5.90 | CSS, SwissHealth Ventures, Mutschler Ventures and PilotRock Ventures | The company will expand its team, drive internationalization and growth and further develop the online platform. |
OnlineDoctor is a Switzerland-based telemedicine provider
|
Hurdle | Seed funding | $5 | 406 Ventures, Seae Ventures and F-Prime | The latest infusion of cash is expected to help the company grow its team and develop its products. |
Hurdle (formerly Henry Health) a virtual mental health provider that specializes in culturally competent care.
|
Rhino Health | Seed funding | $5 | LionBird Ventures, Arkin Holding and other angel investors | The company did not specify how the funds would be used. |
Rhnio Health is a platform designed to connect health system and AI developers.
|
BotMD | N/A | $5 | Monk’s Hill Ventures, SeaX, XA Network, SGInnovate | The new infusion of cash will be put towards growing the company’s regional footprint. |
The technology was designed to work as a chatbot to help answer doctor’s clinical questions.
|
HealthTensor | Seed funding | $5 | Calibrate Ventures, TenOneTen Ventures, Susa Ventures and individual investors | The company did not specify how the funds would be used. |
HealthTensor is an AI enable clinical decision support tool.
|
Kevala | Seed funding | $4 | Vulcan Capital, Costanoa Ventures, High Alpha and PSL Ventures | The company plans to use the new funds to grow its team, which currently has five members. |
Kevala’s platform helps long-term care facility staff onboard, schedule visits and provide educational material.
|
PayGround | Seed funding | $4 | Triventures and SixThirty | The company said that it wants to execute on its tech road map with the new money. |
The company is a financial healthcare startup.
|
Marani Health | Seed funding | $3.70 | SWL Healthcare Ventures and TFZ Capital. | The new funds are going to be used towards clinical research and development, and a go-to-market plan. |
Marani Health was developed to help remotely monitor expecting parents.
|
Base | N/A | $3.40 | Female Founders Fund, TheVentureCity, Brooklyn Bridge Ventures, Lakehouse, Rosecliff and AmplifyHer Ventures | The company did not specify how the funds would be used. |
The company specializes in At-home lab testing.
|
Sano Genetics | Seed funding | $3.20 | Episode1 Ventures, Ventures. Seedcamp, Cambridge Enterprise, January Ventures and unnamed angel investors | Sano wants to expand its platform and build on its prior research projects into multiple sclerosis, ulcerative colitis and other conditions. |
Sano offers free at-home genome sequencing and data reports that customers can choose to include in health research.
|
Cutback Coach | Seed funding | $3.10 | Stephanie Palmeri of Uncork Capital and other individual investors. | The company did not specify how the funds would be used. |
The platform is focused on helping users cut back on alcohol usage.
|
Aavia | Seed funding | $2.50 | Undisclosed | The recently launched company did not outline specific plans. |
The brand offers a Gen Z-friendly app focused on tracking periods, moods, symptoms and more while providing hormone health-education content and a user community.
|
C. Light Technologies | Seed funding | $2.50 | Creative Ventures, Yamaha Motor Ventures, Wisconsin Investment Partners, Berkeley Skydeck Fund, the Band of Angels, EGB Capital, Monde Green Ventures, Puck Ventures and the Vectors Angel Group | The funds will also go towards getting the product through FDA clearance. |
The team at C. Light Technologies developed a 10-second retinal eye-tracking scan for neurological diseases.
|
Botco.ai | Seed funding | $2.20 | Stout Street Capital, Sterling Road, PHX Ventures and Arizona Tech Investors | The startup said that it will be using its new funds to further develop its product and called out additional integrations with EHRs and marketing automation platforms as part of its road map. |
The company makes a marketing chatbot designed for healthcare enterprises.
|
Maya | Seed funding | $2.20 | Anchorless Bangladesh and the Osiris Group | The company said it will be using the funds to further its international expansion and flesh out its offerings. |
The Bangladesh-based company created a mobile wellbeing assistant.
|
PatchAi | N/A | $2 | UV Cap, SFEM Italia and Healthware Ventures | The funds will allow PatchAi to expand its business to other therapeutic areas and scale internationally. |
PatchAi has developed an empathetic virtual companion that uses AI to personalise the dialogue with patients and collect Conversational Patient Reported Outcomes.
|
Preveta | Seed funding | $2 | MaC Venture Capital and TSVC | The founders told CrunchBase that the funds will go towards the sales and marketing for Preveta. |
The company create a care-coordination software that is able to help engage patients between visits, analyze data and help providers fill in treatment gaps.
|
Daybreak Health | Seed funding | $1.80 | Maven Ventures | With the new money, the company said that it wants to build up its clinical and software engineering team, which it hopes will enable greater reach inside and out of California. |
Daybreak’s online platform connects teens to counselors through live video sessions and a mobile app.
|
Serenno Medical | N/A | $1.50 | Elcam Medical | With this, Elcam will be manufacturing Serenno’s medical device. |
Serenno’s Sentinel is a urine output and intra-abdominal-pressure digital monitoring device for the detection of acute kidney injury.
|
BreatheSuite | N/A | $1.20 | Venture NL, Pluto Investments, Killick Capital and other unnamed private backers. | BreatheSuite said it will use the funds to develop new inhaler add-on products and continue its rollout across North America. |
BreatheSuite is a startup that has built a smart-device attachment for inhalers.
|
Marché Health | Seed funding | $1 | Pandion Optimization Alliance | The company plans to use the money for growth. |
The company aims to build a marketplace for digital health and health IT software.
|
Kenzen | Strategic investment | undisclosed | Examinetics | The companies have begun a marketing agreement where Examinetics will share the Kenzen device with its clients. |
Kenzen builds wearable devices designed to reduce workplace injuries.
|
Gray Matter Analytics | N/A | N/A | How Women Invest | The company is adding new offerings in member retention and behavioral health analytics. |
Gray Matter Analytics is a health data company.
|
See the original post here
About Insightin Health
Insightin Health delivers the industry’s only single platform which provides complete personalized member engagement for each step of the health care journey. The core platform inGAGE™ combines medical, clinical, cognitive, and social determinants of health to recommend the Next Best Action (NBA) for each person. Health plans can improve quality measurements, gain higher member satisfaction, and increase member retention. The simple integration and easy to use inGAGE™ creates an effective shift towards a healthier population for health plans. For more information, visit Insightin Health
Leave a Reply